JP2023502990A5 - - Google Patents
Info
- Publication number
- JP2023502990A5 JP2023502990A5 JP2022528591A JP2022528591A JP2023502990A5 JP 2023502990 A5 JP2023502990 A5 JP 2023502990A5 JP 2022528591 A JP2022528591 A JP 2022528591A JP 2022528591 A JP2022528591 A JP 2022528591A JP 2023502990 A5 JP2023502990 A5 JP 2023502990A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- amino acid
- acid sequence
- sequence containing
- containing seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962936783P | 2019-11-18 | 2019-11-18 | |
| US62/936,783 | 2019-11-18 | ||
| PCT/US2020/061050 WO2021101991A1 (en) | 2019-11-18 | 2020-11-18 | Anti-b7-h3 monoclonal antibody and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023502990A JP2023502990A (ja) | 2023-01-26 |
| JP2023502990A5 true JP2023502990A5 (https=) | 2023-11-21 |
| JP7779484B2 JP7779484B2 (ja) | 2025-12-03 |
Family
ID=75980184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022528591A Active JP7779484B2 (ja) | 2019-11-18 | 2020-11-18 | 抗ｂ７－ｈ３モノクローナル抗体およびその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230014398A1 (https=) |
| EP (1) | EP4061847A4 (https=) |
| JP (1) | JP7779484B2 (https=) |
| KR (1) | KR20220115572A (https=) |
| CN (1) | CN114929748A (https=) |
| AU (1) | AU2020387401A1 (https=) |
| BR (1) | BR112022009482A2 (https=) |
| CA (1) | CA3158235A1 (https=) |
| WO (1) | WO2021101991A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021292488A1 (en) * | 2020-06-15 | 2023-02-02 | Monopar Therapeutics, Inc. | Precision radioimmunotherapeutic targeting of the urokinase plasminogen activator receptor (uPAR) for treatment of severe COVID-19 disease |
| IL308258A (en) | 2021-05-05 | 2024-01-01 | Immatics Biotechnologies Gmbh | Bma031 antigen binding polypeptides |
| CN113683697B (zh) * | 2021-08-27 | 2022-06-17 | 上海祥耀生物科技有限责任公司 | 抗b7-h3抗体、其制备方法及用途 |
| CN119486745A (zh) * | 2023-05-24 | 2025-02-18 | 茂行制药(苏州)有限公司 | 用于靶向b7h3的同种异体嵌合抗原受体t细胞的给药的方法和组合物 |
| CN117777296B (zh) * | 2024-02-28 | 2024-05-28 | 北京肿瘤医院(北京大学肿瘤医院) | B7h3亲和体及其诊疗核素标记物的制备方法与应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004020574A2 (en) * | 2002-08-30 | 2004-03-11 | Raymond Frade | Scfv fragment to human cathepsin l and methods of use |
| MA33208B1 (fr) * | 2009-03-25 | 2012-04-02 | Genentech Inc | Anticorps anti-fgfr3 et procédés d'utilisation de ceux-ci |
| EP2542256B1 (en) * | 2010-03-04 | 2019-05-22 | MacroGenics, Inc. | Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof |
| BR112014003315A2 (pt) * | 2011-08-15 | 2017-03-01 | Univ Chicago | composições e métodos relacionados a anticorpos para a proteína a estafilocócica |
| US9163090B2 (en) * | 2012-05-07 | 2015-10-20 | Cellerant Therapeutics, Inc. | Antibodies specific for CLL-1 |
| KR102485788B1 (ko) * | 2014-08-27 | 2023-01-09 | 메모리얼 슬로안 케터링 캔서 센터 | 항체, 조성물 및 용도 |
| GEP20227398B (en) | 2016-04-15 | 2022-07-25 | Macrogenics Inc | Novel b7-h3 binding molecules, antibody drug conjugates thereof and usage thereof |
| US11332544B2 (en) * | 2016-04-21 | 2022-05-17 | Merck Sharp & Dohme Corp. | Glycan-based antibody-drug conjugates |
| AU2017279550A1 (en) | 2016-06-08 | 2019-01-03 | Abbvie Inc. | Anti-B7-H3 antibodies and antibody drug conjugates |
| CN109843927B (zh) * | 2017-03-06 | 2022-06-21 | 江苏恒瑞医药股份有限公司 | 抗b7-h3抗体、其抗原结合片段及其医药用途 |
| US10233226B2 (en) * | 2017-06-21 | 2019-03-19 | The University Of North Carolina At Chapel Hill | Methods and compositions for chimeric antigen receptor targeting cancer cells |
| CN111944050B (zh) * | 2020-08-19 | 2022-05-13 | 苏州普乐康医药科技有限公司 | 一种抗b7-h3抗体及其应用 |
-
2020
- 2020-11-18 AU AU2020387401A patent/AU2020387401A1/en active Pending
- 2020-11-18 JP JP2022528591A patent/JP7779484B2/ja active Active
- 2020-11-18 CN CN202080092077.XA patent/CN114929748A/zh active Pending
- 2020-11-18 EP EP20889500.3A patent/EP4061847A4/en active Pending
- 2020-11-18 KR KR1020227020683A patent/KR20220115572A/ko active Pending
- 2020-11-18 WO PCT/US2020/061050 patent/WO2021101991A1/en not_active Ceased
- 2020-11-18 US US17/777,946 patent/US20230014398A1/en active Pending
- 2020-11-18 BR BR112022009482A patent/BR112022009482A2/pt unknown
- 2020-11-18 CA CA3158235A patent/CA3158235A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023502990A5 (https=) | ||
| KR102589136B1 (ko) | 항-b7-h3 항체 및 그 용도 | |
| KR102778941B1 (ko) | 글리코실화된 면역체크포인트 단백질에 특이적으로 결합하는 항체를 선택하는 방법 | |
| US10494435B2 (en) | Human monoclonal antibodies specific for CD22 | |
| AU2013259850B2 (en) | Antibodies specific for CLL-1 | |
| JP4898120B2 (ja) | Ｇｐｒ６４に対する抗体とその利用法 | |
| US11858960B2 (en) | Human PD-L1-binding immunoglobulins | |
| JP2023517252A5 (https=) | ||
| CN112533633A (zh) | Cd4的抗原结合构建体 | |
| HK1258375A1 (zh) | 人源化抗-cll-1抗体 | |
| JP2022548777A5 (https=) | ||
| JP2023537002A5 (https=) | ||
| JP7512413B2 (ja) | 抗ｐｄ－ｌ１およびｐｄ－ｌ２抗体ならびにその誘導体および用途 | |
| KR20220161362A (ko) | 다중특이적 항체를 작제하기 위한 플랫폼 | |
| JP2023524102A5 (https=) | ||
| JP2024001073A5 (https=) | ||
| WO2022093694A1 (en) | Polypeptides targeting hpv peptide-mhc complexes and methods of use thereof | |
| CN120943967A (zh) | TriAx抗体的组合物及其制备和使用方法 | |
| CN118302445A (zh) | 抗cd155抗体和抗原结合片段及其使用方法 | |
| WO2025067496A1 (zh) | 靶向baff-r的全人源抗体、car-t细胞及其应用 | |
| JP2022524175A (ja) | Ｅｌｔｄ１に対するモノクローナル抗体及びその使用 | |
| CN112823168A (zh) | 结合her2的四聚体多肽 | |
| CN112533948A (zh) | 与双触角Lewis B以及Lewis Y抗原结合的治疗性抗体 | |
| TWI889766B (zh) | 抗cd19抗體以及使用與製造其的方法 | |
| WO2025151746A1 (en) | Methods and compositions for the treatment of pou2f3-driven cancer |